Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Substance Withdrawal Syndrome 1Opioid-Related Disorders 1Lymphoma, Follicular 1

Interventions

Standard of Care 2salicylhydroxamic acid 1X-Rays 1Ultrasonic Waves 1Tirzepatide 1Therapeutics 1Sublocade 1Radiography, Abdominal 1Morphine 1Methadone 1Hematologic Tests 1Educational Status 1Dosage Forms 1Buprenorphine, Naloxone Drug Combination 1Buprenorphine 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Opioid-Related Disorders × salicylhydroxamic acid × Lymphoid × Clear all
NCT04850664 2021-08-06

CBOT-OUD

Evon Medics LLC

Phase 2 Unknown
190 enrolled
Lymphoid

Lymphoma, Follicular, Opioid-Related Disorders, Substance Withdrawal Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡